semaglutide after roux-en-y gastric bypass weight regain helps patients who gain bariatric surgery GLP-1 After Gastric Bypass: Weight

Rotate between these areas and within each area to prevent tissue changes

Unused funds are forfeited at yearend unless the plan offers a grace period or allows carryovers up to 20% of the annual limit ($680 for 2026)

Novo Nordisk is testing an IL6 inhibitor, Ziltivekimab, which cut hsCRP levels by ~80-90% in the phase 2 trial: The phase 3 trial is measuring the hard outcomes: cardiovascular death, myocardial infarction, or stroke, in people with established cardiovascular disease, chronic kidney disease, and persistent inflammation

Heavy drinkers and smokers tend to have lower B12 levels too

On average, patients using Tirzepatide can expect to lose between 15% to 20% of their starting body weight over a period of about 72 weeks, depending on the dosage and adherence to their treatment plan

Activates both GIP and GLP-1 receptors